Literature DB >> 18354375

Summary of notifiable diseases--United States, 2006.

Scott J N McNabb1, Ruth Ann Jajosky, Patsy A Hall-Baker, Deborah A Adams, Pearl Sharp, Carol Worshams, Willie J Anderson, Aponte J Javier, Gerald J Jones, David A Nitschke, Araceli Rey, Michael S Wodajo.   

Abstract

The Summary of Notifiable Diseases--United States, 2006 contains the official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable infectious diseases in the United States for 2006. Unless otherwise noted, the data are final totals for 2006 reported as of June 30, 2007. These statistics are collected and compiled from reports sent by state and territorial health departments to the National Notifiable Diseases Surveillance System (NNDSS), which is operated by CDC in collaboration with the Council of State and Territorial Epidemiologists (CSTE). The Summary is available at http://www.cdc.gov/mmwr/summary.html. This site also includes publications from previous years.

Entities:  

Mesh:

Year:  2008        PMID: 18354375

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  32 in total

1.  Serologic detection of a rare case of Q fever in New York City having hepatic and unusual renal complications.

Authors:  C S Pavia; C McCalla
Journal:  Infection       Date:  2010-04-08       Impact factor: 3.553

2.  Pertussis in Florida, 2000-2006: trends in a historically low-incidence state.

Authors:  Joann M Schulte; Robyn Kay; Janet J Hamilton; Cathy Mellinger; Phyllis Yambor; Christie Luce; Dawn Ginzl; Julia Gill; Richard S Hopkins
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

3.  Domestic understanding of the revised International Health Regulations.

Authors:  Rebecca Katz; Heather Allen
Journal:  Public Health Rep       Date:  2009 Nov-Dec       Impact factor: 2.792

4.  A vision of the journey ahead: using public health notifiable condition mapping to illustrate the need to maintain value sets.

Authors:  Shaun Grannis; Daniel Vreeman
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

5.  Rubella Surveillance and Diagnostic Testing among a Low-Prevalence Population, New York City, 2012-2013.

Authors:  Beth M Isaac; Jane R Zucker; Francesca R Giancotti; Emily Abernathy; Joseph Icenogle; Jennifer L Rakeman; Jennifer B Rosen
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

6.  Quantitative proteomics of the Neisseria gonorrhoeae cell envelope and membrane vesicles for the discovery of potential therapeutic targets.

Authors:  Ryszard A Zielke; Igor H Wierzbicki; Jacob V Weber; Philip R Gafken; Aleksandra E Sikora
Journal:  Mol Cell Proteomics       Date:  2014-03-08       Impact factor: 5.911

7.  Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Authors:  Preeta Krishnan Kutty; Jacqueline Lawler; Elizabeth Rausch-Phung; Ismael R Ortega-Sanchez; Stephen Goodell; Cynthia Schulte; Lynn Pollock; Barbara Valure; Jean Hudson; Kathleen Gallagher; Debra Blog
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

8.  DNA microarray analysis of Salmonella serotype Typhimurium strains causing different symptoms of disease.

Authors:  Eva Litrup; Mia Torpdahl; Burkhard Malorny; Stephan Huehn; Morten Helms; Henrik Christensen; Eva M Nielsen
Journal:  BMC Microbiol       Date:  2010-03-31       Impact factor: 3.605

9.  Independent inactivation of arginine decarboxylase genes by nonsense and missense mutations led to pseudogene formation in Chlamydia trachomatis serovar L2 and D strains.

Authors:  Teresa N Giles; Derek J Fisher; David E Graham
Journal:  BMC Evol Biol       Date:  2009-07-16       Impact factor: 3.260

10.  Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops.

Authors:  Jessica G Cole; Ann E Jerse
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.